These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Platelet aggregation inhibitors. 4. N 6 -substituted adenosines. Kikugawa K; Iizuka K; Ichino M J Med Chem; 1973 Apr; 16(4):358-64. PubMed ID: 4716180 [No Abstract] [Full Text] [Related]
9. Inhibition by phenol and phenolic acids of platelet release reaction. Molinas FC Thromb Diath Haemorrh; 1973 Nov; 30(2):334-8. PubMed ID: 4773371 [No Abstract] [Full Text] [Related]
10. Inhibition of human platelet aggregation by dimethylsulfoxide, dimethylacetamide, and sodium glycerophosphate. Holtz GC; Davis RB Proc Soc Exp Biol Med; 1972 Oct; 141(1):244-8. PubMed ID: 5082296 [No Abstract] [Full Text] [Related]
11. Effects in vivo of -(p-(fluoren-9-ylidenemethyl)phenyl)-2-piperidineethanol (RMI 10,393) on platelet aggregation and blood coagulation. MacKenzie RD; Blohm TR; Steinbach JM Biochem Pharmacol; 1972 Mar; 21(5):707-17. PubMed ID: 4112160 [No Abstract] [Full Text] [Related]
12. Influence of benzamidine derivatives on platelet function. Glusa E; Markwardt F; Hoffmann A Acta Univ Carol Med Monogr; 1972; 53():215-9. PubMed ID: 4670730 [No Abstract] [Full Text] [Related]
13. Acetylenic analog of arachidonate that acts like aspirin on platelets. Willis AL; Kuhn DC; Weiss HJ Science; 1974 Jan; 183(4122):327-30. PubMed ID: 4809077 [TBL] [Abstract][Full Text] [Related]
14. 6-methyl-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolin-2-one, a potent inhibitor of ADP-induced platelet aggregation. Beverung WN; Partyka RA J Med Chem; 1975 Feb; 18(2):224-5. PubMed ID: 1120996 [No Abstract] [Full Text] [Related]
15. Effects of saturated and unsaturated fatty acids on blood platelet aggregation in vitro and after injection into rabbits. Prost RJ; Dvojakovic M; Bara L; Samama M Acta Univ Carol Med Monogr; 1972; 53():403-7. PubMed ID: 4670745 [No Abstract] [Full Text] [Related]
16. Substituted 3,4-pentadienyldiamines as inhibitors of platelet aggregation. Tilford CH; MacKenzie RD; Blohm TR; Grisar JM J Med Chem; 1973 Jun; 16(6):688-93. PubMed ID: 4715003 [No Abstract] [Full Text] [Related]
17. Antithrombotic activity of a newly synthesized coumarin derivative 3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-N-{2-[3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-propionylamino]-ethyl}-propionamide. Jain M; Surin WR; Misra A; Prakash P; Singh V; Khanna V; Kumar S; Siddiqui HH; Raj K; Barthwal MK; Dikshit M Chem Biol Drug Des; 2013 Apr; 81(4):499-508. PubMed ID: 23534412 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of anti-thrombotic activity of benzocoumarin amide derivatives. Sashidhara KV; Palnati GR; Avula SR; Singh S; Jain M; Dikshit M Bioorg Med Chem Lett; 2012 May; 22(9):3115-21. PubMed ID: 22483393 [TBL] [Abstract][Full Text] [Related]
19. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid. Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437 [TBL] [Abstract][Full Text] [Related]
20. The inhibitory effect of metergoline (an anti-5-hydroxytryptaminic agent) on rabbit platelet aggregation. Fregnan GB Pharmacology; 1972; 7(2):115-25. PubMed ID: 5054073 [No Abstract] [Full Text] [Related] [Next] [New Search]